Five notes:
1. Net sales grew 115.9% year-over-year, according to a news release.
2. The company also saw net income of $31.8 million. However that figure is a 45% decrease compared to net income in the second quarter of 2023.
3. Globus Medical projects full-year revenue to reach $2.47 to $2.49 billion.
4. Sales increases were driven by the integration of NuVasive and increased volume of spine and enabling technology sales.
5. Musculoskeletal sales were $592.9 million, and enabling technology sales were $36.8 million.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
